As of June 14th, 2021, Philips Respironics has issued a recall on several of it's devices. They issued this recall due to the sound abetment foam in certain CPAP, BiLevel PAP devices, and Mechanical Ventilators, degrading and potentially causing health risks.
Any of the following devices, that were manufactured before April 26th, 2021 are affected.
- E30 (Emergency Use Authorization)
- Dreamstation - ASV
- Dreamstation - ST, AVAPS
- SystemOne - ASV4
- C Series - ASV, S/T, AVAPS
- OmniLab Advanced Plus - In-Lab Titration Device
- SystemOne - Q Series
- Dreamstation - CPAP, Auto CPAP, BiPAP
- Dreamstation GO - CPAP, APAP
- Dorma 400, 500 - CPAP
- REMStar SE Auto - CPAP
- A-Series BiPAP V30 Auto - Ventilator
The following devices are not affected by the recall notification.
- Trilogy Evo
- Trilogy Evo OBM
- Trilogy EV300
- Trilogy 202
- BiPAP A40 EFL
- BiPAP A40 Pro
- M-Series
- DreamStation 2
- Omnilab (original based on Harmony 2)
- Dorma 100, Dorma 200, & REMStar SE
- All oxygen concentrators, respirator drug delivery products, airway clearance products
Philips Respironics did notice a link between patient's that were using unapproved cleaning methods (such as ozone cleaners) and further degradation of the foam. They are asking that anyone using an ozone cleaner (such as the SoClean) to please discontinue using it.
ATL staff is working quickly and diligently to gather information and progress to the next steps of how the recall process is going to be handled. All patient's using a Respironics device should be receiving a letter from Respironics, explaining further, and possible actions to be made. While we await more information from the manufacture, we appreciate everyone's understanding and patience. We ask that if you have any questions or concerns for ATL to please come into either of our offices. One of our friendly staff members, would be happy to assist. you. Below is a link to the Philips Respironics website, that further discusses the recall.
Philips Respironics 2021 Recall